These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 16406648)
1. Serum proteomic signature for cystic fibrosis using an antibody microarray platform. Srivastava M; Eidelman O; Jozwik C; Paweletz C; Huang W; Zeitlin PL; Pollard HB Mol Genet Metab; 2006 Apr; 87(4):303-10. PubMed ID: 16406648 [TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease. Roxo-Rosa M; da Costa G; Luider TM; Scholte BJ; Coelho AV; Amaral MD; Penque D Proteomics; 2006 Apr; 6(7):2314-25. PubMed ID: 16518875 [TBL] [Abstract][Full Text] [Related]
3. Mapping the lung proteome in cystic fibrosis. Gharib SA; Vaisar T; Aitken ML; Park DR; Heinecke JW; Fu X J Proteome Res; 2009 Jun; 8(6):3020-8. PubMed ID: 19354268 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185 [TBL] [Abstract][Full Text] [Related]
5. High-throughput antibody microarrays for quantitative proteomic analysis. Lv LL; Liu BC Expert Rev Proteomics; 2007 Aug; 4(4):505-13. PubMed ID: 17705708 [TBL] [Abstract][Full Text] [Related]
7. A cancer protein microarray platform using antibody fragments and its clinical applications. Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494 [TBL] [Abstract][Full Text] [Related]
8. Proteomic biomarker discovery for the monogenic disease cystic fibrosis. Penque D Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456 [TBL] [Abstract][Full Text] [Related]
9. Antibody microarrays as an experimental platform for the analysis of signal transduction networks. Korf U; Henjes F; Schmidt C; Tresch A; Mannsperger H; Löbke C; Beissbarth T; Poustka A Adv Biochem Eng Biotechnol; 2008; 110():153-75. PubMed ID: 18528667 [TBL] [Abstract][Full Text] [Related]
10. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. Li Y; Dang TA; Shen J; Perlaky L; Hicks J; Murray J; Meyer W; Chintagumpala M; Lau CC; Man TK Proteomics; 2006 Jun; 6(11):3426-35. PubMed ID: 16673437 [TBL] [Abstract][Full Text] [Related]
15. Dysfunction of the non-neuronal cholinergic system in the airways and blood cells of patients with cystic fibrosis. Wessler I; Bittinger F; Kamin W; Zepp F; Meyer E; Schad A; Kirkpatrick CJ Life Sci; 2007 May; 80(24-25):2253-8. PubMed ID: 17346753 [TBL] [Abstract][Full Text] [Related]
16. Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins. Ingvarsson J; Larsson A; Sjöholm AG; Truedsson L; Jansson B; Borrebaeck CA; Wingren C J Proteome Res; 2007 Sep; 6(9):3527-36. PubMed ID: 17696517 [TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin. Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679 [TBL] [Abstract][Full Text] [Related]
19. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis. Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606 [TBL] [Abstract][Full Text] [Related]
20. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation. Van Biervliet S; Van Biervliet JP; Vande Velde S; Robberecht E Biol Trace Elem Res; 2007 Oct; 119(1):19-26. PubMed ID: 17914215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]